Clinical Trials List
Protocol NumberALKS 2680‑304
Not yet recruiting
2026-08-01 - 2027-10-31
Phase III
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 吳孟霓 Division of Neurology
Co-Principal Investigator
- Yu-Shu Huang Division of Psychiatry
Co-Principal Investigator
- 金韋志 Division of Psychiatry
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
138 participants